Elevate Medical Affairs Podcast Channel

Transitioning between Pharma and MedTech…and vice versa: ep 1 Podcast Objectives, Panel Introductions and Personal Stories

February 27, 2020 Medical Affairs Professional Society Season 2020 Episode 10
Transitioning between Pharma and MedTech…and vice versa: ep 1 Podcast Objectives, Panel Introductions and Personal Stories
Elevate Medical Affairs Podcast Channel
More Info
Elevate Medical Affairs Podcast Channel
Transitioning between Pharma and MedTech…and vice versa: ep 1 Podcast Objectives, Panel Introductions and Personal Stories
Feb 27, 2020 Season 2020 Episode 10
Medical Affairs Professional Society

Hosts John Pracyk, MD, PhD, MBA, Worldwide Integrated Leader, Medical Affairs, Pre-Clinical & Clinical Research, Depuy Synthes - Spine | Johnson & Johnson Medical Devices Companies and Marc Rubinstein, MD, Medical Director at Instrumentation Laboratory, welcome panelists Huub Kreuwel PhD, Vice President of Scientific and Medical Affairs at Octapharma, and Sean Lilienfeld MBBCh, MMEd(Neuro), FCP (Neuro), FAAN, a neurologist by training, and currently Vice President of Global Medical Affairs Clinical Operations, Pre-Clinical Research, and Clinical Strategy at Boston Scientific, two professionals who have successfully transitioned careers between MedTech and Pharma, and reciprocally, Pharma and MedTech.

Show Notes

Hosts John Pracyk, MD, PhD, MBA, Worldwide Integrated Leader, Medical Affairs, Pre-Clinical & Clinical Research, Depuy Synthes - Spine | Johnson & Johnson Medical Devices Companies and Marc Rubinstein, MD, Medical Director at Instrumentation Laboratory, welcome panelists Huub Kreuwel PhD, Vice President of Scientific and Medical Affairs at Octapharma, and Sean Lilienfeld MBBCh, MMEd(Neuro), FCP (Neuro), FAAN, a neurologist by training, and currently Vice President of Global Medical Affairs Clinical Operations, Pre-Clinical Research, and Clinical Strategy at Boston Scientific, two professionals who have successfully transitioned careers between MedTech and Pharma, and reciprocally, Pharma and MedTech.